Relevance of Palladium to Radiopharmaceutical Development Considering Enhanced Coordination Properties of TE1PA.
Ontology highlight
ABSTRACT: The limited use of palladium-103 and -109 radionuclides for molecular radiotherapy is surely due to the lack of appropriate ligands capable of fulfilling all criteria required for application in nuclear medicine. Furthermore, the thermodynamic properties of these complexes in solution remain difficult to establish. The challenge is compounded when considering that radiolabeling of compounds for translation to clinical trials requires fast complexation. Thus, the coordination of Pd(II) and 103/109 Pd-nuclides is a huge challenge in terms of molecular design and physicochemical characterization. Herein, we report a comprehensive study highlighting TE1PA, a monopicolinate cyclam - already established in nuclear imaging with 64 Cu-PET (positron emission tomography) imagin
SUBMITTER: Pineau J
PROVIDER: S-EPMC9401000 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA